Tyzack and colleagues demonstrated that astrocytes obtained from iPSCs of ALS patients carrying the SOD1 mutation disrupted the EphB1 receptor and the downstream protective pathway [109]. Here, SOD1 is linked to amyotrophic lateral sclerosis.